M&A Deal Summary

Aranscia Acquires YouScript

On November 15, 2023, Aranscia acquired software company YouScript from Invitae

Acquisition Highlights
  • This is Aranscia’s 1st transaction in the Software sector.
  • This is Aranscia’s 1st transaction in the United States.
  • This is Aranscia’s 1st transaction in Washington.

M&A Deal Summary
Date 2023-11-15
Target YouScript
Sector Software
Buyer(s) Aranscia
Sellers(s) Invitae
Deal Type Divestiture

Target

YouScript

Seattle, Washington, United States
YouScript is a clinical decision support and analytics platform. Its software pairs a patient's pharmacogenetic profile with published drug and gene interaction information to assess the risk of adverse drug events and possible side effects. YouScript was established in 2016 and is based in Seattle, Washington.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Aranscia

Houston, Texas, United States
Category Company
Sector Software
DESCRIPTION

Aranscia delivers diagnostic software, services, and testing innovations that help clinicians improve care outcomes. Its portfolio of companies, which includes 2bPrecise, AccessDx Laboratory, SinguLab, and YouScript, has extensive practical expertise in molecular diagnostics, genomics, and digital-first clinical workflows. Aranscia enables clinical organizations to effectively utilize precision diagnostics for turnkey programs in fields such as pharmacogenomics, infectious disease management, precision oncology, and genetic screening. With a dual focus on simplicity and scalability, the company's portfolio companies are the ideal partners for long-term, value-based precision medicine initiatives. Aranscia is based in Houston, Texas.

DEAL STATS #
Overall 1 of 1
Sector (Software) 1 of 1
Type (Divestiture) 1 of 1
State (Washington) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1

Seller(S) 1

SELLER

Invitae

San Francisco, California, United States
Category Company
Founded 2010
Sector Life Science
Employees1,700
Revenue 516M USD (2022)
DESCRIPTION

Invitae is a genetic information company diagnostics for hereditary disorders. Invitae was founded in 2010 and is based in San Francisco, California.

DEAL STATS #
Overall 2 of 3
Sector (Software) 1 of 1
Type (Divestiture) 2 of 3
State (Washington) 1 of 1
Country (United States) 2 of 3
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-20 ArcherDX

Boulder, Colorado, United States

ArcherDX is a genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable, and easy to use in local settings. ArcherDX was formed in 2013 and is headquartered in Boulder, Colorado.

Sell $48M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-22 Invitae - Reproductive Health Assets

San Francisco, California, United States

Invitae's Reproductive Health Assets is engaged in the prenatal screening and carrier screening business. Invitae's Reproductive Health Assets is based in San Francisco, California.

Sell -
Mergr

Product

Company

Legal